Recovery Peptide Glossary: BPC-157, TB-500, GHK-Cu, and the Terms Behind the Headlines

The recovery world has its own vocabulary. Scroll one fitness forum and you will hit a wall of letters and numbers. BPC-157. TB-500. GHK-Cu. People drop these terms like everyone already knows them. Most people do not. They nod along and quietly feel lost. This glossary fixes that, one plain definition at a time.

A recovery peptide glossary is a plain-language reference that defines the terms people use online when they talk about peptides and tissue repair. This page defines each term neutrally. It does not endorse, recommend, dose, or offer any compound. None of the named compounds is an FDA-approved drug, and several were discussed by an FDA advisory committee in July 2026.

Think of this as a dictionary, not a how-to. We define the word. We note where it sits with regulators. We stop there. No protocols, no sourcing tips, no "ask your provider to prescribe it." Just the meaning behind the headline.

What you will learn

• What the most common recovery peptide terms actually mean
• The plain-English definition of BPC-157, TB-500, and GHK-Cu
• The difference between a peptide, a protein, and an amino acid
• What words like "stack," "compounding," and "503A" refer to
• Where each named compound stands with the FDA right now

Before any specific compound, you need three plain words. A peptide is a short chain of amino acids. Amino acids are the building blocks of protein. A protein is a long, folded chain of those same blocks. Size is the whole difference. These three terms anchor everything else on this page.

Get these straight and the rest reads easily. Skip them and every headline stays foggy. So we start here, with the unglamorous basics.

Peptide

A peptide is a short chain of amino acids, usually fewer than about 50, linked together. Your body makes thousands of them naturally. They often act as signals, telling cells to do something specific. Insulin is a peptide. So is the hormone that signals fullness. The word itself is neutral; it describes a size and shape of molecule, not a product.

Amino acid

An amino acid is the smallest building block in this family. There are 20 common ones, and your body strings them together in different orders to make peptides and proteins. Think of amino acids as letters. Peptides are short words. Proteins are full sentences. Same alphabet, different length.

Protein

A protein is a long chain of amino acids that folds into a complex three-dimensional shape. Muscle, enzymes, and antibodies are all proteins. The line between a long peptide and a small protein is fuzzy, and scientists draw it loosely around chain length. For this glossary, just remember: short equals peptide, long equals protein.

Now the terms that pull the search traffic. Each one below gets a neutral definition and a clear regulatory-status line. Read the status line every time. It is the part the headlines leave out, and it is the part that matters most.

A quick, blanket note before the entries. None of the compounds defined below is FDA-approved for tissue repair, injury recovery, or general healing. Several were on the agenda of the FDA Pharmacy Compounding Advisory Committee meeting on July 23 to 24, 2026, which discussed whether they should be allowed as bulk ingredients in 503A pharmacy compounding ¹. An advisory committee gives FDA advice. It does not approve drugs. Definitions are not endorsements.

BPC-157

BPC-157 is a synthetic peptide whose name stands for "body protection compound," followed by a number. It is a lab-made fragment loosely based on a protein found in gastric juice. Online, people associate it with tissue and gut repair. The honest evidence picture is early. A 2025 systematic review found 36 studies on its use in muscle, tendon, ligament and bone injury, and 35 of them were preclinical (animal or lab) studies ³.

Current status. BPC-157 is not FDA-approved for tissue repair, injury recovery, or any healing use. It was on the agenda of the FDA Pharmacy Compounding Advisory Committee meeting on July 23 to 24, 2026 ¹. FDA has noted that it may pose a risk for immunogenicity and that there is little safety information on it ². Review is not approval, and listing it here is a definition, not an offer, a dose, or a recommendation.

TB-500

TB-500 is a synthetic version of a fragment of a naturally occurring protein called thymosin beta-4, which plays a role in cell movement and repair signaling. People online connect it to muscle and soft-tissue recovery. FDA has said it has not identified human exposure data for this substance ².

Current status. TB-500 is not FDA-approved for recovery or healing uses. It was also on the agenda of that July 23 to 24, 2026 advisory committee meeting ¹. This entry defines the term. It does not endorse, dose, or provide a way to obtain anything.

GHK-Cu

GHK-Cu is a copper-binding peptide. The letters refer to its three amino acids, and "Cu" is the chemical symbol for copper, which the peptide carries. It occurs naturally in the body and is studied mostly in the context of skin and wound research. It appears in some cosmetic formulations. Its use as an injected recovery compound is a separate matter. FDA has noted limited data in humans ².

Current status. GHK-Cu is not FDA-approved as a drug for tissue repair or recovery. Topical cosmetic use is regulated differently from compounded drug use. GHK-Cu was not on the July 2026 advisory committee agenda ¹. Defined here, not offered here.

A note on the other names you will see

You will also run into terms like KPV, MOTS-C, Epitalon, Semax, and DSIP (also called emideltide) in the same threads. They are different peptides studied for different proposed purposes, and all five were on the same July 2026 advisory committee agenda ¹. We are naming them only so the words are not a mystery. The same rule applies to all of them: not FDA-approved for these uses, evidence largely early, no dose or source from us.

Beyond compound names, the recovery conversation has its own slang and a few real regulatory words worth defining. Two of these, "compounding" and "503A," are technical and genuinely useful. The rest is internet shorthand. Knowing them helps you read a thread without getting swept up in it.

Compounding

Compounding is the practice of a licensed pharmacy preparing a medication tailored to an individual patient, based on a specific prescription from a licensed provider. It is a real, regulated activity. It is also the legal mechanism at the center of the peptide debate, because whether certain peptides can be compounded is exactly what the FDA advisory committee discussed in July 2026 ¹. For what happened at that meeting, see our meeting explainer.

503A

503A refers to a section of federal law that governs traditional pharmacy compounding for an individual patient under a patient-specific prescription. When you see "503A," it points to that regulated, prescription-based pathway, as opposed to large-scale manufacturing. The term matters because legitimate compounded medicine flows through a licensed, inspected pharmacy, not an anonymous online seller.

Stack

A "stack" is informal slang for combining several compounds at once. It is borrowed from supplement and gym culture. We define the word so you recognize it in the wild. We are not describing any combination, schedule, or amount, because none of that is established, appropriate, or part of this glossary.

Gray market

The gray market refers to the unregulated online sellers who ship compounds directly to consumers, usually with no physician, no patient-specific prescription, and no verified testing. Without a licensed pharmacy, there is no assurance of what is in the vial, and FDA has flagged impurity concerns for some of these peptides ². The term is a warning label, not a shopping aisle.

A glossary gives you words. It cannot give you judgment. So here is the filter to carry when you see these terms used in the wild. The space is loud, and the loudest voices usually want a sale. A few questions keep you grounded and safe.

When any brand or seller uses these words, the standard you should demand is simple. A good provider starts with a licensed physician's evaluation, is honest that the human evidence for most of these compounds is early, makes no guarantees, and works only with licensed, inspected pharmacies under patient-specific prescriptions. If a brand cannot point to all of that, walk away. (This is the standard sipra is built around, which is why we publish definitions and education right now, not offers, while the science and the rules are still being settled.)

Notice what that did not do. It did not tell you to buy anything. There is nothing to buy on this page. It is a dictionary.

Frequently asked questions

What is BPC-157 in simple terms? BPC-157 is a synthetic peptide whose name stands for "body protection compound." Online, people link it to tissue and gut repair, but most published evidence comes from animal and lab studies, not human trials ³. It is not FDA-approved for these uses. It was on the agenda of an FDA advisory committee meeting on July 23 to 24, 2026 ¹.

What does TB-500 stand for? TB-500 refers to a synthetic version of a fragment of thymosin beta-4, a protein involved in repair signaling. It is not FDA-approved for recovery uses, and FDA has said it has not identified human exposure data for it ². It was on the same July 2026 FDA advisory committee agenda ¹.

Is GHK-Cu the same as the copper peptide in skincare? GHK-Cu is a copper-binding peptide that appears in some cosmetic formulations, where it is regulated as a cosmetic. Its use as an injected recovery drug is a different, compounded-drug matter, and it is not FDA-approved for that use ². A licensed physician is the right person to ask about your situation.

Are any of these compounds FDA-approved? The named recovery peptides on this page are not FDA-approved for tissue repair, injury recovery, or general healing. Several were discussed by the FDA Pharmacy Compounding Advisory Committee on July 23 to 24, 2026 ¹. Review is not approval.

Does this page tell me how to take any of these? No. This is a definitional glossary. It does not provide doses, schedules, combinations, or sources, and it does not recommend any compound. Any consideration belongs in a conversation with a licensed physician.

The recovery peptide vocabulary is not as mysterious as it looks. BPC-157, TB-500, and GHK-Cu are specific lab-made or naturally occurring peptides that the internet talks about far more confidently than the evidence supports. Now you can define each one. That is real power.

But a definition is where this page stops. None of these compounds is FDA-approved for the uses people discuss, several were discussed by an FDA advisory committee in July 2026, and the gray market that sells them is poorly policed ¹². Knowing the words does not make the products proven or safe.

Here is your three-step action stack.

1. Keep the definitions, drop the hype. Use this page to understand the terms, then judge every claim against the honest evidence, which for most of these is early ³.
2. Watch the real news. Follow what FDA does after its July 2026 advisory committee meeting ¹, without treating any meeting as a green light. Review is not approval.
3. Demand the standard. If you ever explore anything in this category, insist on a licensed physician's evaluation, honest evidence talk, no guarantees, and a licensed, inspected pharmacy. Anything less is a reason to walk away.

That is the glossary. Words defined, status stated, no product attached. Just the meaning behind the headlines.